James P Yee
Insider
First SEC filing: July 16, 2014 · Latest: July 16, 2014
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 1, 2019 | CDNA | M | 19,875 | · | · | 7,125 Direct | -73.61% | Disposed | (price as of 2026-10-02) |
| July 1, 2019 | CDNA | S 10b5-1 | 20,000 | $35.65 | $713,000 | 42,045 Direct | -32.23% | Disposed | 88.4% (price as of 2026-10-02) |
| July 1, 2019 | CDNA | M 10b5-1 | 19,875 | $2.30 | $45,712 | 62,045 Direct | +47.13% | Acquired | 2819.6% (price as of 2026-10-02) |
| June 17, 2019 | CDNA | M | 20,000 | · | · | 15,000 Direct | -57.14% | Disposed | (price as of 2026-10-02) |
| June 17, 2019 | CDNA | S 10b5-1 | 20,000 | $37.54 | $750,800 | 42,170 Direct | -32.17% | Disposed | 78.9% (price as of 2026-10-02) |
| June 17, 2019 | CDNA | M 10b5-1 | 20,000 | $6.49 | $129,800 | 62,170 Direct | +47.43% | Acquired | 934.7% (price as of 2026-10-02) |
| June 3, 2019 | CDNA | F | 1,239 | $32.80 | $40,639 | 42,170 Direct | -2.85% | Disposed | 104.7% (price as of 2026-10-02) |
| March 12, 2019 | CDNA | S 10b5-1 | 7,598 | $35.18 | $267,298 | 43,409 Direct | -14.90% | Disposed | 90.9% (price as of 2026-10-02) |
| March 1, 2019 | CDNA | F | 3,685 | $31.64 | $116,593 | 51,007 Direct | -6.74% | Disposed | 112.2% (price as of 2026-10-02) |
| March 1, 2019 | CDNA | A | 10,000 | · | · | 54,692 Direct | +22.38% | Acquired | (price as of 2026-10-02) |
| Feb. 12, 2019 | CDNA | M | 3,649 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Feb. 12, 2019 | CDNA | M | 3,649 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Feb. 12, 2019 | CDNA | S 10b5-1 | 32,500 | $23.88 | $776,100 | 44,692 Direct | -42.10% | Disposed | 181.2% (price as of 2026-10-02) |
| Feb. 12, 2019 | CDNA | M 10b5-1 | 3,649 | $3.97 | $14,487 | 77,192 Direct | +4.96% | Acquired | 1591.4% (price as of 2026-10-02) |
| Feb. 12, 2019 | CDNA | M 10b5-1 | 3,649 | $3.70 | $13,501 | 73,543 Direct | +5.22% | Acquired | 1714.9% (price as of 2026-10-02) |
| Feb. 4, 2019 | CDNA | A | 16,000 | · | · | 16,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 4, 2019 | CDNA | F | 2,766 | $27.17 | $75,152 | 69,894 Direct | -3.81% | Disposed | 147.1% (price as of 2026-10-02) |
| Feb. 4, 2019 | CDNA | A | 8,000 | · | · | 72,660 Direct | +12.37% | Acquired | (price as of 2026-10-02) |
| Feb. 4, 2019 | CDNA | A | 8,000 | · | · | 64,660 Direct | +14.12% | Acquired | (price as of 2026-10-02) |
| Jan. 28, 2019 | CDNA | F | 845 | $27.46 | $23,204 | 56,660 Direct | -1.47% | Disposed | 144.5% (price as of 2026-10-02) |
| Jan. 22, 2019 | CDNA | F | 2,139 | $25.05 | $53,582 | 57,505 Direct | -3.59% | Disposed | 168.1% (price as of 2026-10-02) |
| June 29, 2018 | CDNA | F | 3,458 | $12.24 | $42,326 | 59,644 Direct | -5.48% | Disposed | 448.6% (price as of 2026-10-02) |
| June 29, 2018 | CDNA | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 29, 2018 | CDNA | A | 10,000 | · | · | 63,102 Direct | +18.83% | Acquired | (price as of 2026-10-02) |
| June 29, 2018 | CDNA | A | 10,000 | · | · | 53,102 Direct | +23.20% | Acquired | (price as of 2026-10-02) |
| Jan. 29, 2018 | CDNA | F | 805 | $6.25 | $5,031 | 43,102 Direct | -1.83% | Disposed | 974.4% (price as of 2026-10-02) |
| Jan. 22, 2018 | CDNA | F | 1,691 | $6.29 | $10,636 | 43,907 Direct | -3.71% | Disposed | 967.6% (price as of 2026-10-02) |
| Jan. 19, 2018 | CDNA | A | 20,000 | · | · | 20,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 8, 2017 | CDNA | M | 29,197 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Dec. 8, 2017 | CDNA | S | 29,197 | $7.00 | $204,379 | 45,598 Direct | -39.04% | Disposed | 859.3% (price as of 2026-10-02) |
| Dec. 8, 2017 | CDNA | M | 29,197 | $3.36 | $98,102 | 74,795 Direct | +64.03% | Acquired | 1898.5% (price as of 2026-10-02) |
| Nov. 9, 2017 | CDNA | A | 13,359 | · | · | 13,359 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 8, 2017 | CDNA | D | 21,897 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 1, 2017 | CDNA | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 17, 2017 | CDNA | A | 27,000 | · | · | 27,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 17, 2017 | CDNA | A | 10,000 | · | · | 45,598 Direct | +28.09% | Acquired | (price as of 2026-10-02) |
| Oct. 28, 2016 | CDNA | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 22, 2016 | CDNA | A | 33,000 | · | · | 33,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 22, 2016 | CDNA | A | 11,000 | · | · | 35,598 Direct | +44.72% | Acquired | (price as of 2026-10-02) |
| March 6, 2015 | CDNA | A | 35,000 | · | · | 35,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 6, 2015 | CDNA | A | 10,000 | · | · | 24,598 Direct | +68.50% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 1, 2019 | CDNA | Employee Stock Option (right to buy) | Common Stock | $2.30 | Feb. 17, 2027 | 19,875 | Disposed |
| June 17, 2019 | CDNA | Employee Stock Option (right to buy) | Common Stock | $6.49 | March 6, 2025 | 20,000 | Disposed |
| Feb. 12, 2019 | CDNA | Option to Purchase Common Stock | Common Stock | $3.97 | Aug. 27, 2020 | 3,649 | Disposed |
| Feb. 12, 2019 | CDNA | Option to Purchase Common Stock | Common Stock | $3.70 | April 8, 2020 | 3,649 | Disposed |
| Feb. 4, 2019 | CDNA | Employee Stock Option (right to buy) | Common Stock | $27.17 | Feb. 4, 2029 | 16,000 | Acquired |
| June 29, 2018 | CDNA | Employee Stock Option (right to buy) | Common Stock | $12.24 | June 29, 2028 | 10,000 | Acquired |
| Jan. 19, 2018 | CDNA | Employee Stock Option (right to buy) | Common Stock | $6.31 | Jan. 19, 2028 | 20,000 | Acquired |
| Dec. 8, 2017 | CDNA | Employee Stock Option (right to buy) | Common Stock | $3.36 | Jan. 1, 2018 | 29,197 | Disposed |
| Nov. 9, 2017 | CDNA | Option to Purchase Common Stock [F3] | Common Stock | · | Nov. 9, 2024 | 13,359 | Acquired |
| Nov. 8, 2017 | CDNA | Option to Purchase Common Stock | Common Stock | $12.40 | April 8, 2024 | 21,897 | Disposed |
| Sept. 1, 2017 | CDNA | Employee Stock Option (right to buy) | Common Stock | $2.80 | Sept. 1, 2027 | 10,000 | Acquired |
| Feb. 17, 2017 | CDNA | Employee Stock Option (right to buy) | Common Stock | $2.30 | Feb. 17, 2027 | 27,000 | Acquired |
| Oct. 28, 2016 | CDNA | Employee Stock Option (right to buy) | Common Stock | $3.67 | Oct. 28, 2026 | 10,000 | Acquired |
| Jan. 22, 2016 | CDNA | Employee Stock Option (right to buy) | Common Stock | $5.27 | Jan. 22, 2026 | 33,000 | Acquired |
| March 6, 2015 | CDNA | Employee Stock Option (right to buy) | Common Stock | $6.49 | March 6, 2025 | 35,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 16, 2014 | CDNA | Common Stock | 14,598 | Direct |
| July 16, 2014 | CDNA | Option to Purchase Common Stock | 14,598 | Direct |
| July 16, 2014 | CDNA | Option to Purchase Common Stock | 29,197 | Direct |
| July 16, 2014 | CDNA | Option to Purchase Common Stock | 3,649 | Direct |
| July 16, 2014 | CDNA | Option to Purchase Common Stock | 3,649 | Direct |
| July 16, 2014 | CDNA | Option to Purchase Common Stock | 21,897 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $247,401 | · | $652,080 | $278,446 | · | · | $300 | $1,178,227 |
| 2017 | $382,905 | · | · | · | $184,800 | · | · | $697,495 |
| 2016 | $376,620 | · | · | · | $112,986 | · | · | $634,321 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.